Get started
Author

Jonathan Faughn

Observed names: Jon D. Faughn, Jon Faughn, Jonathan D Faughn
ORCID: 0000-0002-5009-0871
Observed ORCID: 0000-0002-5009-0871
OpenAlex ID: A5073724736
Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor
2013 · Kavitha Yaddanapudi, Kalyani Putty, et al. · The Journal of Immunology · 182
Immunotherapy in breast cancer: Current status and future directions
2019 · Amrita Basu, Ganesan Ramamoorthi, et al. · Advances in cancer research · 109
Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge
2022 · Nicholas Piccicacco, Kristen Zeitler, et al. · Journal of Antimicrobial Chemotherapy · 64
PDF
The N‐terminal methyltransferase homologs NRMT1 and NRMT2 exhibit novel regulation of activity through heterotrimer formation
2018 · Jon D. Faughn, William L. Dean, et al. · Protein Science · 16
PDF
The N-terminal methyltransferase homologs NRMT1 and NRMT2 exhibit novel regulation of activity through heterotrimer formation.
2018 · Jon Faughn · 1
PDF
Abstract 1544: Control of tumor-associated macrophage alternative activation by MIF.
2013 · Kavitha Yaddanapudi, Kalyani Putty, et al. · Cancer Research
Works count: 6
Citation count: 372
H-index: 4
I10-index: 4
Year
Topic
Type